David Bogucki

Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of Na_V1.7 with Efficacy in Rodent Pain Models

Thilo Focken, Shifeng Liu, Navjot Chahal et al. · ACS Medicinal Chemistry Letters · 2016 · 72 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and Structure−Activity Relationships of Azamacrocyclic C-X-C Chemokine Receptor 4 Antagonists: Analogues Containing a Single Azamacrocyclic Ring are Potent Inhibitors of T-Cell Tropic (X4) HIV-1 Replication

Gary Bridger, Renato T. Skerlj, Pedro E. Hernandez-Abad et al. · Journal of Medicinal Chemistry · 2009 · 56 citations

Medicine, Medicinal Chemistry, Pharmacology +17

An Asymmetric Synthesis of (-)-Deoxypodophyllotoxin

David Bogucki, James L. Charlton · The Journal of Organic Chemistry · 1995 · 47 citations

Natural Sciences, Chemistry, Pharmacology +7

Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication

Renato T. Skerlj, Gary Bridger, Curtis Harwig et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

A non-enzymatic synthesis of (<i>S</i>)-(−)-rosmarinic acid and a study of a biomimetic route to (+)-rabdosiin

David Bogucki, James L. Charlton · Canadian Journal of Chemistry · 1997 · 37 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +11